News & Analysis on Clinical Trial Services & Contract Research And Development
By Melissa Fassbender
- Last updated on
Julie Forget who has joined Altasciences as the director of toxicology said she is looking forward to supporting the company’s study directors in their overall responsibility for the scientific conduct of a study “and assist with the implementation of additional scientific capabilities at our preclinical site.”
“As a team, we will focus on protocol development to design custom and flexible approaches to meet our clients’ needs.
"Constant communication and collaboration are key elements for success, which translate into a more efficient and effective way to bring new drugs to patients,” she said.